Therapeutic Asset Ratings
1,179 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Adavosertib
Primary Peritoneal Serous Adenocarcinoma
M.D. Anderson Cancer Center
Early P1
C
(39)
Adavosertib
Fallopian Tube Cancer
M.D. Anderson Cancer Center
Early P1
C
(39)
ALTEPLASE
Hematopoietic And Lymphoid Cell Neoplasm
M.D. Anderson Cancer Center
Early P1
C
(39)
Pembrolizumab
Smoldering Plasma Cell Myeloma
M.D. Anderson Cancer Center
Early P1
C
(39)
TECHNETIUM TC 99M SESTAMIBI
Estrogen-Receptor Negative Breast Cancer
M.D. Anderson Cancer Center
Early P1
C
(39)
TECHNETIUM TC 99M SESTAMIBI
Her2-Receptor Negative Breast Cancer
M.D. Anderson Cancer Center
Early P1
C
(39)
TECHNETIUM TC 99M SESTAMIBI
Progesterone-Receptor Negative Breast Cancer
M.D. Anderson Cancer Center
Early P1
C
(39)
TECHNETIUM TC 99M SESTAMIBI
Triple-Negative Breast Carcinoma
M.D. Anderson Cancer Center
Early P1
C
(39)
Grapiprant
Inflammatory Breast Carcinoma
M.D. Anderson Cancer Center
P1/2
C
(39)
Momelotinib
Myeloid Leukemia
M.D. Anderson Cancer Center
P1/2
C
(39)
Zn-C3
Neoplasm
M.D. Anderson Cancer Center
P1
C
(38)
Adagrasib
Refractory Malignant Neoplasm
M.D. Anderson Cancer Center
Early P1
C
(38)
ALTEPLASE
Cancer
M.D. Anderson Cancer Center
Early P1
C
(38)
Encorafenib
Refractory Malignant Neoplasm
M.D. Anderson Cancer Center
Early P1
C
(38)
PANITUMUMAB
Refractory Malignant Neoplasm
M.D. Anderson Cancer Center
Early P1
C
(38)
Sotorasib
Refractory Malignant Neoplasm
M.D. Anderson Cancer Center
Early P1
C
(38)
TIPIRACIL
Refractory Malignant Neoplasm
M.D. Anderson Cancer Center
Early P1
C
(38)
Trifluridine
Refractory Malignant Neoplasm
M.D. Anderson Cancer Center
Early P1
C
(38)
Tucatinib
Refractory Malignant Neoplasm
M.D. Anderson Cancer Center
Early P1
C
(38)
Adagrasib
Colon Carcinoma
M.D. Anderson Cancer Center
P1
C
(37)
FUROSEMIDE
Melanoma
M.D. Anderson Cancer Center
P1
C
(37)
G 207
Neoplasm
M.D. Anderson Cancer Center
P1
C
(37)
il-15 enhanced engineered nk cells
Hodgkins Lymphoma
M.D. Anderson Cancer Center
P1
C
(37)
Immunoglobulin G1 [de-236-glycine,267-glutamic acid,de-C-terminal lysine], anti-(human tumor necrosis factor receptor TNFRSF9) (human-Mus musculus monoclonal LVGN6051 ?1-chain), disulfide with human-Mus musculus monoclonal LVGN6051 ?-chain, dimer
Gastric Cancer
M.D. Anderson Cancer Center
P1
C
(37)
Immunoglobulin G1 [de-236-glycine,de-C-terminal lysine], anti-(human CD40 antigen) (human monoclonal LVGN7409 ?1-chain), disulfide with human monoclonal LVGN7409 ?-chain, dimer
Gastric Cancer
M.D. Anderson Cancer Center
P1
C
(37)
Showing 1101 to 1125 of 1,179 assets
Previous
Page 45 of 48
Next
